Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology

by Brian J. Miller, David R. Goldsmith
Published 2019-12-01

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits

by David R. Goldsmith, Mark Hyman Rapaport
Published 2020-02-01

Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion

by Justin K. Ellis, Elaine F. Walker, David R. Goldsmith
Published 2020-09-01

Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects

by Bradley D. Pearce, Nicholas Massa, Nicholas Massa, David R. Goldsmith, Zeal H. Gandhi, Allison Hankus, Alaaeddin Alrohaibani, Neha Goel, Bruce Cuthbert, Bruce Cuthbert, Molly Fargotstein, Dana Boyd Barr, Parinya Panuwet, Victoria M. Brown, Erica Duncan, Erica Duncan
Published 2020-11-01